Prospective and retrospective, single-cohort, multicenter observational long-term study in short children born small for gestational age (SGA) after treatment with Saizen® or with other recombinant human growth hormone (r-hGH) products (SALTO) First published 02/12/2016 Last updated 07/06/2024 EU PAS number:EUPAS16520 Study Ongoing